Skip to main content
. Author manuscript; available in PMC: 2021 Dec 16.
Published in final edited form as: ACS Bio Med Chem Au. 2021 Sep 10;1(1):31–43. doi: 10.1021/acsbiomedchemau.1c00021

Figure 1.

Figure 1.

Schematic representation of particle components (A); β−1,3-glucan (green), gold nanoparticle (gold) and MUC4 glycopeptide antigen (red/dark blue curved line; red = linker, blue = glycopeptide); tetrapeptide -GFLG- was inserted as a cathepsin B cleavage site. (B) Combined nanoparticle used for in vivo production of specific immune responses in mice.